[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$f1fb4it85cjrdl":5},{"data":4},[],{"data":6,"error":11},{"id":7,"documentId":8,"slug":9,"name":10,"proprietary_name":11,"non_proprietary_name":11,"is_proprietary":11,"active_ingredient":11,"administration_route":11,"available_strength":11,"dosage_form":11,"dose_schedule":11,"drug_unit":11,"is_available_generically":11,"mechanism_of_action":11,"overdosage":11,"warning":11,"species":12,"citations":13,"dose_schedules":24,"available_strengths":32,"label_statements":37,"drug_classes":42,"specialties":53,"medical_conditions":54,"animal_species":55},1629,"d5g23rxstu0jqbrw4jdgjy5u","acetylsalicylic-acid","acetylsalicylic acid",null,[],[14,20],{"source":15,"licence":16,"source_url":17,"harvested_by":18,"retrieved_at":19},"FDA Green Book","US public domain","https:\u002F\u002Fanimaldrugsatfda.fda.gov\u002Fadafda\u002Fapp\u002Fsearch\u002Fpublic\u002FingredientsInformationExcel\u002FSection2ActiveIngredients","load-reference-corpus.cjs","2026-09-07",{"source":21,"licence":22,"source_url":23,"harvested_by":18,"retrieved_at":19},"UK VMD PID","OGL v3.0","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002Fproductinformationdatabase\u002Fdownloads\u002Fvmd_productinformationdatabase.xlsx",[25],{"id":26,"dose_text":27,"species":28,"administration_route":29,"limitation":30,"source_label":31},11171,"Dogs under 15 pounds, 1\u002F4 to 1 tablet daily;\n15 to 60 pounds, 1 to 2 tablets daily;\n60 pounds and over, 2 tablets daily.","Dogs","Oral","Administer total daily dose in divided doses 6 to 10 hours apart, with a light feeding. When response is attained, dosage should be gradually reduced until maintenance level is achieved. Do not administer to cats. Do not overdose. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Systemic therapy with methylprednisolone is contraindicated in animals with tuberculosis, chronic nephritis, peptic ulcer, or Cushingoid syndrome. The presence of diabetes mellitus, osteoporosis predisposition to thrombophlebitis, hypertension, congestive heart failure, or renal insufficiency necessitates carefully controlled use of corticosteroids. Anti-inflammatory action of corticosteroids may mask signs of infection.","Cortaba® Tablets",[33],{"id":34,"strength_text":35,"dosage_form":36,"proprietary_name":31,"species":28,"source_label":31},9806,"Each tablet contains 0.5 milligram of methylprednisolone and 300 milligrams of aspirin.","Tablet",[38],{"id":39,"kind":40,"statement":41,"species":28,"limitation":30,"source_label":31},16113,"indication","As an anti-inflammatory and analgesic agent in dogs.",[43,48],{"id":44,"documentId":45,"slug":46,"name":47},872,"kw0ggntl0eqjvin7cbr5lz4p","platelet-aggregation-inhibitor","Platelet Aggregation Inhibitor",{"id":49,"documentId":50,"slug":51,"name":52},882,"rol85x8fhez2srv1tdxcrykh","nonsteroidal-anti-inflammatory-drug","Nonsteroidal Anti-inflammatory Drug",[],[],[]]